| Effects of the cyclooxygenase inhibiting nitric oxide donator naproxcinod versus naproxen on systemic blood pressure in patients with osteoarthritis. | |
| | |
MedLine Citation:
|
PMID: 19733721 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Traditional nonsteroidal anti-inflammatory drugs are associated with the destabilization of blood pressure (BP) control, particularly in hypertensive patients treated with blockers of the renin-angiotensin system. To assess the potential impact of nitric oxide donation, the effects of naproxcinod with naproxen and placebo on changes in BP were compared in a randomized clinical trial of 916 patients with osteoarthritis after 13 weeks of therapy. In addition, the effects of naproxcinod versus naproxen and placebo on systolic BP in patients with hypertension treated with renin-angiotensin system blockers were evaluated. Naproxcinod 750 mg twice daily reduced systolic BP compared to naproxen 500 mg twice daily (p <0.02). The 2 doses of naproxcinod showed reductions from baseline in diastolic BP relative to naproxen (p <0.04) and similar changes compared to placebo. In 207 patients with hypertension treated with renin-angiotensin-blocking agents alone or with diuretics, the difference in mean change from baseline in systolic BP between naproxen 500 mg and naproxcinod 750 mg was 6.5 mm Hg in favor of naproxcinod (p <0.02). The proportion of patients in the overall population with systolic BP increases > or =10 mm Hg was greater with naproxen 500 mg (22%) compared to naproxcinod 750 mg (14%, p = 0.04), naproxcinod 375 mg (14%, p = 0.055), and placebo (15.6%, p = 0.155). In conclusion, naproxcinod did not induce elevations of BP seen with naproxen, and it had similar effects on BP to that of placebo in patients with osteoarthritis. |
| | |
Authors:
|
William B White; Thomas J Schnitzer; Rosanna Fleming; Brigitte Duquesroix; Maarten Beekman |
Publication Detail:
|
Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial |
Journal Detail:
|
Title: The American journal of cardiology Volume: 104 ISSN: 1879-1913 ISO Abbreviation: Am. J. Cardiol. Publication Date: 2009 Sep |
Date Detail:
|
Created Date: 2009-09-07 Completed Date: 2009-09-25 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0207277 Medline TA: Am J Cardiol Country: United States |
Other Details:
|
Languages: eng Pagination: 840-5 Citation Subset: AIM; IM |
Affiliation:
|
Pat and Jim Calhoun Cardiology Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA. wwhite@nso1.uchc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aged Anti-Inflammatory Agents, Non-Steroidal / administration & dosage, pharmacology*, therapeutic use Blood Pressure / drug effects*, physiology Comorbidity Double-Blind Method Female Humans Hypertension / drug therapy, epidemiology* Male Middle Aged Naproxen / administration & dosage, analogs & derivatives*, pharmacology* Nitric Oxide Donors / administration & dosage, pharmacology* Osteoarthritis / epidemiology*, physiopathology |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Inflammatory Agents, Non-Steroidal; 0/Nitric Oxide Donors; 0/naproxen-n-butyl nitrate; 22204-53-1/Naproxen |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Role of renin-angiotensin system blockade in patients with diabetes mellitus.
Next Document: Effect of balloon valvuloplasty in patients with severe aortic stenosis on levels of N-terminal pro-...